These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2328446)

  • 1. Dose-dependent inhibition of cyclosporine metabolism in mice by fluconazole.
    La Delfa I; Xia YF; Blaschke TF
    Can J Physiol Pharmacol; 1990 Jan; 68(1):89-93. PubMed ID: 2328446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluconazole is a potent inhibitor of antipyrine metabolism in vivo in mice.
    La Delfa I; Zhu QM; Mo Z; Blaschke TF
    Drug Metab Dispos; 1989; 17(1):49-53. PubMed ID: 2566469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluconazole: a potent inhibitor of cytochrome P-450-dependent drug-metabolism in mice and humans in vivo. Comparative study with ketoconazole.
    Morita K; Konishi H; Shimakawa H
    Chem Pharm Bull (Tokyo); 1992 May; 40(5):1247-51. PubMed ID: 1394641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible interaction between warfarin and fluconazole.
    Gericke KR
    Pharmacotherapy; 1993; 13(5):508-9. PubMed ID: 8247921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug interactions with fluconazole.
    Lazar JD; Wilner KD
    Rev Infect Dis; 1990; 12 Suppl 3():S327-33. PubMed ID: 2330488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ketoconazole inhibits cyclosporine metabolism in vivo in mice.
    Anderson JE; Blaschke TF
    J Pharmacol Exp Ther; 1986 Mar; 236(3):671-4. PubMed ID: 3950868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of ketoconazole and fluconazole as cytochrome P450 inhibitors. Use of steady-state infusion approach to achieve plasma concentration-response relationships.
    Ervine CM; Matthew DE; Brennan B; Houston JB
    Drug Metab Dispos; 1996 Feb; 24(2):211-5. PubMed ID: 8742233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of fluconazole on antipyrine kinetics in rats.
    Ramzan I; Chan M
    Eur J Drug Metab Pharmacokinet; 1993; 18(3):273-6. PubMed ID: 8149946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of cytochromes P-450 in cyclosporine metabolism.
    Watkins PB
    J Am Acad Dermatol; 1990 Dec; 23(6 Pt 2):1301-9; discussion 1309-11. PubMed ID: 2277139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo evaluation of the effects of altered cyclosporine metabolism on its immunosuppressive potency.
    Babany G; Morris RE; Babany I; Shepherd S; Kates RE
    J Pharmacol Exp Ther; 1989 Mar; 248(3):893-9. PubMed ID: 2649657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of fluconazole and fluvoxamine on the pharmacokinetics and pharmacodynamics of glimepiride.
    Niemi M; Backman JT; Neuvonen M; Laitila J; Neuvonen PJ; Kivistö KT
    Clin Pharmacol Ther; 2001 Apr; 69(4):194-200. PubMed ID: 11309547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic interaction of fluconazole and zidovudine in HIV-positive patients.
    Brockmeyer NH; Tillmann I; Mertins L; Barthel B; Goos M
    Eur J Med Res; 1997 Sep; 2(9):377-83. PubMed ID: 9300934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Voriconazole and fluconazole increase the exposure to oral diazepam.
    Saari TI; Laine K; Bertilsson L; Neuvonen PJ; Olkkola KT
    Eur J Clin Pharmacol; 2007 Oct; 63(10):941-9. PubMed ID: 17676319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Warfarin-fluconazole. I. Inhibition of the human cytochrome P450-dependent metabolism of warfarin by fluconazole: in vitro studies.
    Kunze KL; Wienkers LC; Thummel KE; Trager WF
    Drug Metab Dispos; 1996 Apr; 24(4):414-21. PubMed ID: 8801056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction between cyclosporine and fluconazole in renal allograft recipients.
    Canafax DM; Graves NM; Hilligoss DM; Carleton BC; Gardner MJ; Matas AJ
    Transplantation; 1991 May; 51(5):1014-8. PubMed ID: 2031258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlations between cytochrome P-450 and oxidative metabolism of benzo[a]pyrene and 7-ethoxycoumarin in human liver in vitro and antipyrine elimination in vivo.
    Pelkonen O; Sotaniemi E; Tokola O; Ahokas JT
    Drug Metab Dispos; 1980; 8(4):218-22. PubMed ID: 6105054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ranitidine alters antipyrine metabolism in control and phenobarbital-treated mice.
    Espiritu-Quiza MF; Skinner MH; Blaschke TF
    Methods Find Exp Clin Pharmacol; 1990 Nov; 12(9):631-6. PubMed ID: 2084458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Teratological interaction between the bis-triazole antifungal agent fluconazole and the anticonvulsant drug phenytoin.
    Tiboni GM; Iammarrone E; Giampietro F; Lamonaca D; Bellati U; Di Ilio C
    Teratology; 1999 Feb; 59(2):81-7. PubMed ID: 10069438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the antifungals voriconazole and fluconazole on the pharmacokinetics of s-(+)- and R-(-)-Ibuprofen.
    Hynninen VV; Olkkola KT; Leino K; Lundgren S; Neuvonen PJ; Rane A; Valtonen M; Vyyryläinen H; Laine K
    Antimicrob Agents Chemother; 2006 Jun; 50(6):1967-72. PubMed ID: 16723553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Warfarin-fluconazole. II. A metabolically based drug interaction: in vivo studies.
    Black DJ; Kunze KL; Wienkers LC; Gidal BE; Seaton TL; McDonnell ND; Evans JS; Bauwens JE; Trager WF
    Drug Metab Dispos; 1996 Apr; 24(4):422-8. PubMed ID: 8801057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.